PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Sinclair & Co.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Biotigen’s Ophthalmic Imaging System Receives CE Mark - Envisu™ medical device now approved for use in European Union clinical market - Bioptigen.com
Biotigen’s Ophthalmic Imaging System Receives CE Mark

 

NewswireToday - /newswire/ - Research Triangle Park, NC, United States, 2011/12/15 - Envisu™ medical device now approved for use in European Union clinical market - Bioptigen.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Bioptigen Inc., an ISO 13485-certified medical device company that develops innovative ophthalmologic imaging technologies, has received regulatory approval to market its hand-held Envisu C2000-series systems for clinical use within the European Union.

Bioptigen’s Envisu spectral domain optical coherence tomography imaging systems use low-power, near-infrared light to generate real-time, high-resolution, depth-resolved images of eye structures – equipping researchers and clinicians to explore new avenues of understanding in disease progression, detection and treatment.

“Earning a CE Mark is an important milestone for Bioptigen, but it’s even more meaningful for the pediatric and adult patients who now can benefit from our more flexible imaging platform. We bring imaging to the patient; the patient doesn’t have to come to us,” said Dr. Eric Buckland, president and CEO. “Knowing that Bioptigen can improve the quality of life for patients is extremely rewarding.”

Bioptigen’s Envisu C2000 series should prove especially useful for physicians treating non-ambulatory patients, as well as those suffering from conditions such as nystagmus, which causes involuntary eye movement, Buckland added.

“Physicians in Europe play a critical role when it comes to advancing non-invasive medical technologies,” Buckland said. “Bioptigen looks forward to collaborating with these professionals as they develop new best practices based on standards that benefit patients worldwide.”

Deployed in the top 10 U.S. ophthalmic research institutions, Bioptigen devices are covered by 60-plus patent applications, including 30 awarded patents. More than 100 scientific articles have been published citing data acquired with Bioptigen technologies.

Availability of Envisu C-series held-hand clinical ophthalmic imaging systems in the United States is dependent upon review and market clearance by the U.S. Food and Drug Administration.

The National Institutes of Health recently awarded Bioptigen a grant to investigate a compact, hand-held device for use with premature and neonatal infants.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Sinclair & Co.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Biotigen’s Ophthalmic Imaging System Receives CE Mark

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Karen Stinneford - Sinclair-Co.com 
919-833-9102 kstinneford[.]sinclair-co.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sinclair & Co. securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Sinclair & Co. / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

ZOLL Expands the Rescuer Experience at EMS Today
Traditional Mass Spectrometers Give Way to High-resolution Technologies Such as MALDI-TOF Finds Frost & Sullivan
AccuVein, Inc. Named A Best Place to Work in Medical Sales for Second Consecutive Year
MRI Inventor to Receive the Medtech Innovation Catalyst Award
Ansell Limited Acquires Cleanroom and Healthcare Consumables Manufacturer Nitritex Limited
ZOLL to Showcase Expanded Portfolio of Advanced Resuscitation and Acute Critical Care Technologies at Arab Health 2017
Frost & Sullivan Awards Ansell for Entrenching itself in the Hand Protection Market with its Visionary Products and Technologies
ZOLL RescueNet ePCR Achieves Latest National Compliance Standard
Eye Tech Care Wins Top Honours from Frost & Sullivan for Developing the EyeOP1, the Only Computer-assisted System for Glaucoma Therapy
Frost & Sullivan Recognizes Nuvectra’s Pioneering Spinal Cord Stimulation Product for Chronic Pain Management
GE Healthcare to Commercialize Rapiscan® Outside the US, Canada & Mexico for Increased Access to Heart Exams
Novel Home Care Needs and Customer Preferences Catalyse Growth Opportunities in Mature Cardiac Monitoring Market Finds Frost & Sullivan
Frost & Sullivan Highlights Inspirata's Leading-edge Digital Pathology Solutions that Accelerate Cancer Diagnostics, Monitoring, Treatment
Sparta Systems Broadens Partnership with TrackWise Implementation Specialist Equality Systems
Thales Launches the Pixium Portable 3543 DR Wifi Enabled Flat Panel Detector

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Al Rowaad Advocates & Legal Consultants

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)